Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 17.30
Day High 17.65
Open:17.30
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Halozyme Therapeutics, Inc. is a therapeutically driven, development stage biopharmaceutical company dedicated to developing and commercializing recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The company's broad product development portfolio, including expected near- and long-term product offerings, is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's initial products are being developed to offer safer and purer alternatives toexisting slaughterhouse derived extracts that carry risks of pathogen contamination, immunogenicity, and toxicity. The commercialization of Halozyme's highly versatile enzyme technology within proven markets will enable the company to positively impact the quality of medicine.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Halozyme Appoints Bernadette Connaughton To Board Of Directors
PR Newswire - Mon Sep 10, 7:00AM CDT
PR Newswire - CMTX
Mon Sep 10, 7:00AM CDT
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced the appointment of Bernadette Connaughton to its board of directors. Ms. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the board.
Halozyme Therapeutics To Participate In Upcoming Investor Conferences
PR Newswire - Wed Aug 22, 7:30AM CDT
PR Newswire - CMTX
Wed Aug 22, 7:30AM CDT
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will participate in two upcoming investor conferences.
Today's Research Reports on Trending Tickers: Halozyme Therapeutics and Repligen
ACCESSWIRE - Wed Aug 1, 7:04AM CDT
ACCESSWIRE - CMTX
Wed Aug 1, 7:04AM CDT
NEW YORK, NY / ACCESSWIRE / August 1, 2018 / Wall Street snapped its losing streak on Tuesday as investors digested better-than-expected quarterly earnings and after the Trump administration appeared to have made progress on easing trade disputes with China. The Dow Jones Industrial Average gained 0.43 percent to close at 25,415.19, while the S&P 500 Index was increased 0.49 percent to close at 2,816.29. The Nasdaq Composite Index climbed 0.55 percent to close at 7,671.79.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 16.52 +6.11% increase
on 09/17/18
Period Open:17.22
Price movement based on the high, low and last over the given period.
18.85 -7.00% decrease
on 08/23/18
+0.31 (+1.80%) increase
since 08/21/18
3-Month 16.46 +6.50% increase
on 07/27/18
Period Open:18.59
Price movement based on the high, low and last over the given period.
19.01 -7.79% decrease
on 06/22/18
-1.06 (-5.70%) decrease
since 06/21/18
52-Week 16.06 +9.15% increase
on 02/09/18
Period Open:16.60
Price movement based on the high, low and last over the given period.
21.48 -18.39% decrease
on 03/20/18
+0.93 (+5.60%) increase
since 09/21/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement